Design, Expression, and Immunogenicity of a Soluble HIV Trimeric Envelope Fragment Adopting a Prefusion gp41 Configuration
Open Access
- 1 June 2005
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (24) , 23138-23146
- https://doi.org/10.1074/jbc.m414515200
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Structure of an unliganded simian immunodeficiency virus gp120 coreNature, 2005
- Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide regionProceedings of the National Academy of Sciences, 2001
- Functional Analysis of the Disulfide-Bonded Loop/Chain Reversal Region of Human Immunodeficiency Virus Type 1 gp41 Reveals a Critical Role in gp120-gp41 AssociationJournal of Virology, 2001
- Mechanisms of Viral Membrane Fusion and Its InhibitionAnnual Review of Biochemistry, 2001
- Three-dimensional solution structure of the 44kDa ectodomain of SIV gp41The EMBO Journal, 1998
- The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and ImmunogensScience, 1998
- Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibodyNature, 1998
- Atomic structure of the ectodomain from HIV-1 gp41Nature, 1997
- Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.Proceedings of the National Academy of Sciences, 1994
- Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gpl60Nature, 1992